Two peri-stent contrast stainings and one late restenosis in the late phase after sirolimus-eluting stent implantation  by Ando, Hirohiko et al.
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Both  peri-stent  contrast  staining  (PSS)  and  late restenosis  are  abnormal  ﬁndings  after  drug-eluting  stent
implantation  and  they  occur  with  low  incidence.  We  describe  a  case  with  two PSSs and  one late  restenosiseceived in revised form 1 December 2013
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after  sirolimus-eluting  stent  implantation.  Persistent  high  value  of  C-reactive  protein  in this  patient
suggested  chronic  systematic  inﬂammation  as  a contributing  factor  of  these  abnormal  ﬁndings.
<Learning  objective:  The  advent  of  drug-eluting  stents  has  dramatically  reduced  in-stent  restenosis.
However,  there  are  still  some  concerns  about  long-term  safety.  We  show  a case  with  multiple  sirolimus-
eluting  stent-related  complications,  taking  into  account  the  underlying  pathogenesis.>
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An 80-year-old female who was previously treated with 3
irolimus-eluting stents (SES) was admitted to our hospital due
o exertional angina. She was implanted with the ﬁrst SES at the
roximal left anterior descending artery 7 years previously for the
estenotic lesion of bare-metal stent with complete overlap with a
revious stent which was implanted 8 years previously for de-novo
esion. The second one was implanted at the mid  left circumﬂex
rtery 7 years previously for a de-novo atherosclerotic lesion, and
he last one was implanted at the mid  right coronary artery 5
ears previously for a de-novo atherosclerotic lesion. All SESs were
mplanted at rated burst pressure and intravascular ultrasound per-
ormed shortly after stent implantation identiﬁed no incomplete
tent apposition.
Diagnostic angiography revealed two lesions with peri-stent
ontrast staining (PSS) in the right coronary artery and the left cir-
umﬂex artery, and a 99% late restenosis within the SES implanted
t the left anterior descending artery (Fig. 1). Two PSSs were also
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ttp://dx.doi.org/10.1016/j.jccase.2013.12.008identiﬁed by optical coherence tomography as large free spaces
outside the stent (Fig. 2, Supplementary videos).
Serial angiographies revealed the gradually increasing size of
PSS over time (Fig. 1). For SES implanted at the left anterior
descending artery, in-stent restenosis was  not identiﬁed by follow-
up angiographies performed at 6, 21, and 29 months after SES
implantation. Therefore, this lesion was considered as late resteno-
sis that occurred at 7 years after implantation. At the latest
angiography, there were 2 PSSs and 1 late restenosis in this one
patient.
Discussion
PSS is an abnormal angiographic ﬁnding after drug-eluting stent
implantation with low incidence (1.9% per lesion), and might be a
cause of subsequent very late stent thrombosis [1]. Although the
precise pathogenesis has not been fully elucidated, histopatholog-
ical studies suggested that the presence of chronic inﬂammation
and/or hypersensitive reaction in SES-treated lesions might be a
contributing factor [2].
Late restenosis is usually deﬁned as progression of restenosis
beyond 1 year after stent implantation, and a higher inci-
dence is reported after SES implantation compared to bare-metal
vier Ltd. All rights reserved.
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Fig. 1. Serial angiographies and C-reactive protein values. Dotted lines indicate the location of implanted sirolimus-eluting stent. Arrows indicate restenotic lesion within
the  stent. Arrowheads indicate the site of peri-stent contrast staining. CRP, C-reactive protein; LAD, left anterior descending artery; LCX, left circumﬂex artery; RCA, right
coronary artery.
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tent implantation (4.5% vs. 1.4% at 3 years) [3]. Although the
athogenesis has not been fully elucidated, chronic inﬂammation
s considered to be a possible cause.
Considering that this patient had two PSSs and one late resteno-
is at the same time despite the fact that the incidence of
ach phenomenon is low, common mechanisms such as chronic
nﬂammation might be operative for both PSSs and late resteno-
is after SES implantation. In fact, this patient kept a high value ofn RCA and LCX. RCA, right coronary artery; LCX, left circumﬂex artery.
C-reactive protein throughout the follow-up period without white
blood cell elevation, suggesting that chronic systematic inﬂam-
mation might be a contributing factor for SES-related long-term
complications.Conﬂict of interest
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